Related references
Note: Only part of the references are listed.Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G
Darja Pollpeter et al.
NATURE MICROBIOLOGY (2018)
Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor
Nicole Espy et al.
VIROLOGY (2017)
DNA Editing by APOBECs: A Genomic Preserver and Transformer
Binyamin A. Knisbacher et al.
TRENDS IN GENETICS (2016)
Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants
Edward J. D. Greenwood et al.
ELIFE (2016)
Intrinsic host restrictions to HIV-1 and mechanisms of viral escape
Viviana Simon et al.
NATURE IMMUNOLOGY (2015)
Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-β/RUNX axis
Brett D. Anderson et al.
SCIENCE ADVANCES (2015)
Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission
Benjamin G. Luttge et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All
Belete A. Desimmie et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Quantification of Deaminase Activity-Dependent and -Independent Restriction of HIV-1 Replication Mediated by APOBEC3F and APOBEC3G through Experimental-Mathematical Investigation
Tomoko Kobayashi et al.
JOURNAL OF VIROLOGY (2014)
Ezrin Is a Component of the HIV-1 Virological Presynapse and Contributes to the Inhibition of Cell-Cell Fusion
Nathan H. Roy et al.
JOURNAL OF VIROLOGY (2014)
Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus
John S. Albin et al.
VIROLOGY (2014)
Evidence Showing that Tetraspanins Inhibit HIV-1-Induced Cell-Cell Fusion at a Post-Hemifusion Stage
Menelaos Symeonides et al.
VIRUSES-BASEL (2014)
Natural Polymorphisms in Human APOBEC3H and HIV-1 Vif Combine in Primary T Lymphocytes to Affect Viral G-to-A Mutation Levels and Infectivity
Eric W. Refsland et al.
PLOS GENETICS (2014)
Different Mutagenic Potential of HIV-1 Restriction Factors APOBEC3G and APOBEC3F Is Determined by Distinct Single-Stranded DNA Scanning Mechanisms
Anjuman Ara et al.
PLOS PATHOGENS (2014)
HIV-1 Vif Adaptation to Human APOBEC3H Haplotypes
Marcel Ooms et al.
CELL HOST & MICROBE (2013)
Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5
Zahra F. Parker et al.
JOURNAL OF VIROLOGY (2013)
The Tale of the Long Tail: the Cytoplasmic Domain of HIV-1 gp41
Thomas S. Postler et al.
JOURNAL OF VIROLOGY (2013)
Nuclear import of APOBEC3F-labeled HIV-1 preintegration complexes
Ryan C. Burdick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification of the feline foamy virus Bet domain essential for APOBEC3 counteraction
Dragana Slavkovic Lukic et al.
RETROVIROLOGY (2013)
The Cytoplasmic Domain of the HIV-1 Glycoprotein gp41 Induces NF-κB Activation through TGF-β-Activated Kinase 1
Thomas S. Postler et al.
CELL HOST & MICROBE (2012)
Targeting frameshifting in the human immunodeficiency virus
Lea Brakier-Gingras et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Signals in APOBEC3F N-terminal and C-terminal Deaminase Domains Each Contribute to Encapsidation in HIV-1 Virions and Are Both Required for HIV-1 Restriction
Chisu Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
HIV Entry and Envelope Glycoprotein-mediated Fusion
Robert Blumenthal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection
Stefanie Jaeger et al.
NATURE (2012)
Endogenous Origins of HIV-1 G-to-A Hypermutation and Restriction in the Nonpermissive T Cell Line CEM2n
Eric W. Refsland et al.
PLOS PATHOGENS (2012)
Phosphorylation Directly Regulates the Intrinsic DNA Cytidine Deaminase Activity of Activation-induced Deaminase and APOBEC3G Protein
Zachary L. Demorest et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation
Mary Ann Checkley et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
HIV-1 Gag Extension: Conformational Changes Require Simultaneous Interaction with Membrane and Nucleic Acid
Siddhartha A. K. Datta et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Human and Rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H Demonstrate a Conserved Capacity To Restrict Vif-Deficient HIV-1
Judd F. Hultquist et al.
JOURNAL OF VIROLOGY (2011)
Conformational Changes of the HIV-1 Envelope Protein during Membrane Fusion Are Inhibited by the Replacement of Its Membrane-spanning Domain
Naoyuki Kondo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Long-Term Restriction by APOBEC3F Selects Human Immunodeficiency Virus Type 1 Variants with Restored Vif Function
John S. Albin et al.
JOURNAL OF VIROLOGY (2010)
Topological Layers in the HIV-1 gp120 Inner Domain Regulate gp41 Interaction and CD4-Triggered Conformational Transitions
Andres Finzi et al.
MOLECULAR CELL (2010)
Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain
Vineela Chukkapalli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Species-specific Inhibition of APOBEC3C by the Prototype Foamy Virus Protein Bet
Mario Perkovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Optimal Translation Initiation Enables Vif-Deficient Human Immunodeficiency Virus Type 1 To Escape Restriction by APOBEC3G
Guylaine Hache et al.
JOURNAL OF VIROLOGY (2009)
Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G
Guylaine Hache et al.
CURRENT BIOLOGY (2008)
Human immunodeficiency virus type 1 vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation
Jason L. DeHart et al.
JOURNAL OF VIROLOGY (2008)
Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif
Kotaro Shirakawa et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts
Kate N. Bishop et al.
PLOS PATHOGENS (2008)
The AID/APOBEC family of nucleic acid mutators
Silvestro G. Conticello
GENOME BIOLOGY (2008)
APOBEC3 inhibits mouse mammary tumour virus replication in vivo
Chioma M. Okeoma et al.
NATURE (2007)
Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid
David Derse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation - Comparisons with APOBEC3G
Rebecca K. Holmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Foamy virus bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors
RA Russell et al.
JOURNAL OF VIROLOGY (2005)
The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein
M Löchelt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity
ENC Newman et al.
CURRENT BIOLOGY (2005)
Recovery of APOBEC3-edited human immunodeficiency virus G -> A hypermutants by differential DNA denaturation PCR
R Suspene et al.
JOURNAL OF GENERAL VIROLOGY (2005)
HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles
M Douaisi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 Virions through interactions with viral and nonviral RNAs
ES Svarovskaia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein
TM Alce et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The interaction between HIV-1 Gag and APOBEC3G
S Cen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
APOBEC3G incorporation into human immunodeficiency virus type 1 particles
W Zennou et al.
JOURNAL OF VIROLOGY (2004)
Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging
K Luo et al.
JOURNAL OF VIROLOGY (2004)
Retroviral restriction by APOBEC proteins
RS Harris et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor
A Schäfer et al.
VIROLOGY (2004)
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
H Zhang et al.
NATURE (2003)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
A quantitative assay for HIV DNA integration in vivo
SL Butler et al.
NATURE MEDICINE (2001)
Share Paper
